维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Wacker T"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Correlation be- tween development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase Ⅲ studies 显示文摘	Wacker B Nagrani T Weinberg J	2007	Clin Cancer Res2007，13，13：	1
2	Technetium-99m hexakis-2-methoxyisobutylisonitrile:human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging 显示文摘	Wacker F J T Berman D S Maddahi J	1989	J Nucl Med1989，30，：	1
3	Effect of dimensionality and estimation on the performance of Gaussian classifiers显示文摘	Elshaikl T S Wacker A G	1980	IEEE Trans PAMI1980，2，12：	1
4	Interstellar diamonds in meteorites显示文摘	Lewis R S Ming T Wacker J F	1987	Nature1987，326，：	1
5	Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase Ⅲ studies显示文摘	Wacker B Nagrani T Weinberg J	2007	Clin Cancer Res2007，13，13：	1
6	Toxic effects of superoxide, hy- drogen peroxide,and nitric: oxide on human and pig islets显示文摘	JJahr H Bretzel RG Wacker T	1995	Trans- plant Proc1995，27，6：	1
7	A comparison of two assay methods for assessing fungistasis in soils显示文摘	WACKER T L LOCKWOOD J L	1991	Soil Biol Biochem1991，23，5：	1
8	Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase Ⅲ atudios显示文摘	Wacker B Nagrani T Weinherg J		0，，13：	1
9	Correlation be- tween development of rash and efficacy in patients treated with the epidermal growth factor receptor tyro- sine kinase inhibitor erlotinib in two large phase m studies显示文摘	Wacker B Nagrani T Weinberg J	2007	Clin Cancer Res2007，13，13：	1
10	Digital mammography: an update显示文摘	Sehulz-Wendtland R Fuchsjager M Wacker T	2009	Eur J Radiol2009，72，2：	1
11	Correlation between develop- ment of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase studies显示文摘	Wacker B Nagrani T Weinberg J	2007	Clin Cancer Res2007，13，13：	1
12	Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase studies显示文摘	Wacker B Nagrani T Weinberg J	2007	Clin Cancer Res2007，13，13：	1
13	Correlation between development of rash and efficacy in patients treatedwith the epidermal growth factor receptor tyrosine kinase inhibitor erlo- tinib in two large phase III studies 显示文摘	WACKER B NAGRANI T WEINBERG J	2007	Clin Cancer Res2007，13，13：	1
14	Correlation between devel-opment of rash and efficacy in patients treated with the epidermal-growth factor receptor tyrosine kinase inhibitor erlotinib in two large phaseⅢstudies显示文摘	Wacker B Nagrani T Weinberg J etal	2007	Clin Cancer Res2007，13，：	1
15	Correlation between de-velopment of rash and efficacy in patients treated with the epider-mal growth factor receptor tyrosine kinase inhibitor erlotinib in twolarge phase III studies 显示文摘	Wacker B Nagrani T Weinberg J	2007	Clin Cancer Res2007，13，13：	1
16	Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase Ⅲ studies显示文摘	Wacker B Nagrani T Weinberg J	2007	Clin Cancer Res2007，13，13：	1
17	Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase Ⅲ studies显示文摘	Wacker B Nagrani T Weinberg J	2007	Clin Cancer Res2007，13，13：	1
18	Biodegrada- tion of bisphenol A by Heliscus lugdunensis, a naturally oe- curring hyphomyeete in freshwater environments显示文摘	OMOIKE A WACKER T NAVIDONSKI M	2013	Chemo- sphere2013，91，11：	1
19	Diversity of cereal aphid parasitoids in simple and complex landscapes显示文摘	Vollhardt M G Tscharntke T Wackers F C	2008	Agrieul ture Ecosystems & Environment2008，126，：	1
20	Correlation between development of rash and efficacy in patients treated with the epidermal growth\sfactor receptor tyrosine kinase inhinbitor erlotinib in two large phaseⅢstudies显示文摘	Wacker B Nagrani T Weinberg J	2007	Clin Cancer Res2007，14，13：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示